| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.44▼ | 3.55▼ | 3.58▼ | 4.28▼ | 1.60▲ |
| MA10 | 3.54▼ | 3.62▼ | 3.69▼ | 2.53▲ | 0.96▲ |
| MA20 | 3.62▼ | 3.77▼ | 3.79▼ | 1.40▲ | 0.59▲ |
| MA50 | 3.82▼ | 4.14▼ | 2.98▲ | 0.75▲ | 0.46▲ |
| MA100 | 3.84▼ | 2.62▲ | 1.63▲ | 0.49▲ | 1.05▲ |
| MA200 | 4.78▼ | 1.44▲ | 0.95▲ | 0.39▲ | 15.01▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.019▼ | -0.034▼ | -0.124▼ | 0.342▲ | 0.341▲ |
| RSI | 32.344▼ | 39.615▼ | 46.523▼ | 62.789▲ | 85.160▲ |
| STOCH | 1.258▼ | 8.264▼ | 3.922▼ | 54.465 | 25.290 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -62.258 | -62.258 |
| CCI | -102.189▼ | -168.808▼ | -143.021▼ | 58.744 | 213.291▲ |
|
Wednesday, December 17, 2025 09:10 AM
Processa Pharmaceuticals' stock jumps after Phase 2 data show higher capecitabine exposure without added toxicity in metastatic breast cancer patients.
|
|
Tuesday, June 17, 2025 06:15 AM
Processa Pharmaceuticals, Inc. has announced a licensing agreement with Intact Therapeutics for PCS12852, a novel 5-HT4 receptor agonist aimed at treating gastroparesis and gastrointestinal motility ...
|
|
Friday, June 13, 2025 05:12 AM
Processa Pharmaceuticals, Inc. announced its participation in the 2025 BIO International Convention from June 16-19 in Boston, where key executives, including CEO Georg Ng and President of R&D Dr.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/12/25 | 3.84 | 3.84 | 3.42 | 3.42 | 342,773 |
| 22/12/25 | 3.67 | 4.30 | 3.60 | 3.60 | 562,706 |
| 19/12/25 | 3.78 | 3.9914 | 3.42 | 3.78 | 564,068 |
| 18/12/25 | 4.60 | 4.90 | 3.62 | 3.90 | 2,792,400 |
| 17/12/25 | 3.35 | 8.88 | 3.28 | 6.68 | 39,329,400 |
| 16/12/25 | 3.125 | 3.35 | 2.7375 | 3.0025 | 300,090 |
| 15/12/25 | 0.26 | 0.27 | 0.11 | 0.1415 | 13,080,506 |
| 12/12/25 | 0.2757 | 0.28 | 0.26 | 0.27 | 603,993 |
| 11/12/25 | 0.282 | 0.282 | 0.257 | 0.272 | 1,065,300 |
| 10/12/25 | 0.30 | 0.304 | 0.269 | 0.277 | 983,300 |
|
|
||||
|
|
||||
|
|